Latest updates for Fmdrx
Fresh curated links around FMDRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Veradigm: You Can't Fall Off The Floor
- Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
- Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
finance.yahoo.com
/2 weeks ago
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
finance.yahoo.com
/1 month ago
Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)
seekingalpha.com
/1 month ago
Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day - Slideshow
seekingalpha.com
/2 days ago
Veradigm Inc. (MDRX) Discusses Progress on SEC Filings, Relisting Efforts and Strategic Update Transcript
fool.com
/1 week ago
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
Viridian Therapeutics develops monoclonal antibody therapies targeting serious diseases, with a primary focus on thyroid eye disease.
qchron.com
/1 month ago
FMC Secures Approval for Isoflex® Active in the European Union, Addressing a Critical Gap in the European Herbicide Mark...
fool.com
/2 weeks ago
CorMedix (CRMD) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joseph TodiscoExecutive Vice President and Chief O...
fool.com
/2 weeks ago
CorMedix (CRMD) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joseph TodiscoExecutive Vice President and Chief O...
benzinga.com
/1 month ago
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline
Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026. Importance Rank: ...
fool.com
/1 month ago
Market Street Expands Its DFGX Holdings in $3.5 Million Buy
This ETF provides diversified exposure to global ex-U.S. fixed income, spanning government, corporate, and supranational bonds.
fool.com
/3 weeks ago
TransMedics (TMDX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateTuesday, May 5, 2026, 4:30 p.m. ETCall participantsPresident and Chief Executive Officer — Waleed HassaneinChief Financial Officer — Gerardo Her...
healio.com
/1 month ago
FDA grants breakthrough designation for efimosfermin for MASH
The FDA granted breakthrough therapy designation to efimosfermin — an investigational, once-monthly fibroblast growth factor 21 analogue — for treatment of patients with metabolic...
seekingalpha.com
/1 month ago
Medicenna Therapeutics Corp. (MDNA:CA) Presents at 2026 Bloom Burton & Co. Healthcare Investor Conference - Slidesho...
seekingalpha.com
/3 weeks ago
Tactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process matures
newswire.com
/3 weeks ago
Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for...
Pediatric patients with Intestinal Failure (IF) due to MVID, an ultrarare congenital disorder with lethal natural history, that has no available therapies and needs lifelong total...
benzinga.com
/3 weeks ago
12 Health Care Stocks Moving In Friday's After-Market Session
Importance Rank: 1 read more
pharmexec.com
/1 month ago
<![CDATA[FDA Approves Foundayo Under National Priority Voucher Program]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Fmdrx
feeds.benzinga.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source